WILTON HOUSE LIMITED
Company number 01997746 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Investment Risk Analysis: WILTON HOUSE LIMITED
1. Risk Rating: MEDIUM
Justification: While the company demonstrates strong current operational profitability and cash generation, the significant erosion of net assets from £20.4M (2020) to £7.1M (2024) — a 65% decline — warrants careful scrutiny. This is partially explained by subsidiary disposals and impairments, but the magnitude of the decline, combined with concentrated ownership and industry-specific risks, elevates the overall risk profile above low.
2. Key Concerns
i) Substantial Net Asset Erosion
Net assets have fallen from £20.4M (March 2020) to £7.1M (August 2024), a reduction of approximately £13.3M. While the filed accounts attribute much of this to the disposal of an overseas subsidiary (with impairment provisions and disposal losses of £1,099,999 in the prior period), the scale of the decline suggests significant write-downs on fixed assets or investment properties. The total asset base has nearly halved from £31.6M to £15.6M over the same period. Without full breakdowns of asset revaluations or impairments beyond what is disclosed, the underlying asset quality requires further investigation.
ii) Concentrated Ownership and Control
Mr Nittianund Reekhaye holds more than 75% of shares, more than 75% of voting rights, and the right to appoint and remove directors. This level of control creates significant related-party risk and minority shareholder exposure. Corporate governance is limited — there are only two directors (V S Ramoutar and Mrs R E Reekhaye), and the strategic decisions rest with a single controlling individual. Any adverse personal or financial circumstances affecting the PSC could materially impact the company.
iii) Industry-Specific Operational Risks
The care home sector carries inherent risks including infection outbreaks (as highlighted in the strategic report), staffing recruitment challenges, and regulatory policy changes. The national living wage increase of 9.8% in April 2024 directly impacts staffing costs (which represent a substantial portion of expenditure for a 209-employee operation). Light and heat costs "almost doubled" according to the director's report, indicating margin pressure from energy costs. Occupancy rates are the primary revenue driver, and any disruption could quickly affect cash flows.
3. Positive Indicators
i) Strong Current Operational Performance
Turnover of £9.33M represents a 6.18% increase on a prorated basis, and operating profit of £1.98M yields an operating margin of 21.24% — consistent with the prior period (20.94%). The company has returned to profit before tax of £1.4M after a loss-making period caused primarily by one-off impairment provisions. Net trading profit margin (excluding impairments) remains stable at approximately 14.98%.
ii) Healthy Cash Position and Covenant Compliance
Cash has improved from £957K (August 2023) to £1.2M (August 2024). The company is comfortably meeting its bank loan covenant requirement (EBITDA after dividends ≥ £1.5M), reporting £2.07M against this target. Total liabilities have decreased from £9M (2020) to £6.4M (2024), indicating deleveraging.
iii) Regulatory Compliance and Going Concern
Filing obligations are fully met — accounts and confirmation statements are up to date with no overdue filings. The auditor (Sears Morgan Accountancy Limited) has issued an unqualified opinion with no material uncertainties regarding going concern. The company has been operational for 38 years, demonstrating long-term business resilience.
4. Due Diligence Notes
a) Asset Composition and Valuation
The total assets of £15.6M likely include significant investment properties and care home facilities. The nature of fixed asset valuations and any revaluation reserves should be examined. The accounts reference properties being rented, and the repairs/renewals programme being deferred and prepaid over an estimated 7.5-year useful life — the accounting treatment and adequacy of these provisions should be reviewed.
b) Subsidiary Disposal Details
The overseas trading subsidiary was disposed of effective 31 August 2023, and a UK dormant subsidiary is being struck off the register (application made 31 December 2024). The terms, consideration received, and any ongoing obligations related to these disposals should be investigated. The change of accounting year-end from March to August, while explained, creates comparability challenges.
c) Related Party Transactions
Given the concentrated ownership structure, all transactions between the company, its directors, and the PSC should be examined for arm's-length terms. The minimal dividend of £1,000 may indicate either reinvestment strategy or potential extraction through alternative means.
d) Regulatory Standing
As a residential nursing care provider (SIC 87100), the company is subject to CQC (Care Quality Commission) regulation in England. The current CQC rating, any enforcement actions, and compliance history should be verified independently of these financial statements.
e) Debtor Quality
The strategic report mentions credit exposure to residents and strong credit control procedures. Given that turnover is £9.33M and the company operates in a sector where local authority funding delays are common, the ageing profile of debtors and any bad debt provisions warrant detailed examination.